The Science
How HBOT Supports Brain Health
The brain is one of the most oxygen-dependent organs in the human body, consuming approximately 20% of the body's total oxygen supply despite accounting for only about 2% of body weight. When brain tissue is injured or blood flow is compromised, the resulting oxygen deficit can impair neural function, slow recovery, and contribute to cognitive difficulties. Hyperbaric oxygen therapy (HBOT) addresses this by dramatically increasing the amount of dissolved oxygen in blood plasma, allowing oxygen to reach brain regions that may be underserved by normal circulation.
Under the elevated pressure of a hyperbaric chamber, oxygen dissolves into plasma at levels far exceeding what is possible at normal atmospheric pressure. This oxygen-rich plasma can penetrate areas of the brain with compromised blood flow, supporting cellular metabolism and energy production in neural tissue. Research suggests that this process may help stimulate neuroplasticity, the brain's ability to form new neural connections and reorganize existing pathways, which is fundamental to recovery from brain injuries and to maintaining cognitive function throughout aging.
A landmark series of studies from Tel Aviv University, led by Professor Shai Efrati and colleagues, has demonstrated that HBOT may significantly improve cerebral blood flow and cognitive performance in aging adults. In a randomized controlled trial (Hadanny et al., 2020, published in the journal Aging), healthy adults over 64 years of age who completed a protocol of 60 HBOT sessions showed significant improvements in attention, information processing speed, and executive function compared to a control group. Brain imaging revealed increased cerebral blood flow in regions associated with cognitive decline.
OxyHealth chambers are available in both portable models for home use (operating at 1.3 ATA) and clinical models for medical facilities (capable of higher pressures up to 4.0 ATA). All OxyHealth chambers are FDA-cleared and manufactured under strict quality controls. Individuals considering HBOT for brain health concerns should consult a neurologist or qualified healthcare provider to determine the most appropriate protocol.
Traumatic Brain Injury
HBOT and Traumatic Brain Injury (TBI)
Traumatic brain injury affects millions of people worldwide each year, ranging from mild concussions to severe injuries with lasting cognitive and neurological effects. Research suggests that HBOT may offer supportive benefits for individuals recovering from TBI by increasing oxygen delivery to damaged brain tissue, potentially reducing neuroinflammation, and supporting the brain's natural repair mechanisms.
A pivotal study published in PLOS ONE (Boussi-Gross et al., 2013) examined the effects of HBOT on patients with mild TBI who were 1 to 5 years post-injury and still experiencing persistent cognitive symptoms. The study reported significant improvements in cognitive function, including memory, attention, and executive function, following a course of 40 HBOT sessions at 1.5 ATA. Brain imaging (SPECT scans) showed corresponding improvements in brain activity in regions that had previously shown reduced perfusion.
The U.S. Department of Defense has funded multiple research initiatives investigating HBOT as a potential therapy for military personnel with blast-related traumatic brain injuries. These studies reflect growing interest in understanding whether increased oxygen delivery under pressure can support neural recovery in individuals whose brain injuries have not fully responded to standard rehabilitation approaches.
It is important to note that HBOT is not currently FDA-cleared specifically for the treatment of TBI. Research in this area is ongoing, and individuals considering HBOT for TBI should work closely with a neurologist or brain injury specialist to evaluate whether HBOT may be an appropriate component of their recovery plan.
Concussion Recovery
HBOT and Concussion Recovery
Concussions, classified as a form of mild traumatic brain injury, are particularly common in contact sports, military service, and everyday accidents. Post-concussion syndrome, where symptoms such as headaches, brain fog, difficulty concentrating, and fatigue persist for weeks or months beyond the initial injury, affects a significant proportion of concussion patients. Research is exploring whether HBOT may help support recovery from these persistent symptoms.
Studies published in Frontiers in Human Neuroscience have investigated the effects of HBOT on post-concussion syndrome. Research suggests that the elevated oxygen levels achieved during HBOT sessions may help reduce neuroinflammation, a key factor in persistent concussion symptoms. The increased oxygen supply may also support the repair of microstructural damage to white matter tracts that can occur during concussive impacts, potentially facilitating improved neural signaling and cognitive function.
In the context of sports concussions, there is growing interest among sports medicine physicians and athletic trainers in HBOT as a complementary recovery tool. Many professional sports teams, including those in the NFL and other major leagues, have incorporated OxyHealth hyperbaric chambers into their training facilities, where they are used alongside standard concussion management protocols to support athletes during the recovery process.
As with TBI, HBOT is not FDA-cleared specifically for concussion treatment. However, the growing body of published research and clinical interest has made HBOT an increasingly studied option in the field of concussion recovery. Any individual considering HBOT following a concussion should consult a physician experienced in both concussion management and hyperbaric medicine.
Cognitive Support
HBOT and Cognitive Decline
As the global population ages, cognitive decline has become one of the most significant health concerns worldwide. Research suggests that reduced cerebral blood flow and diminished oxygen delivery to brain tissue play a central role in age-related cognitive changes. HBOT is being studied as a potential intervention to address these underlying mechanisms by restoring oxygen supply to oxygen-deprived brain regions.
The Tel Aviv University research program, one of the most comprehensive investigations into HBOT and aging, has produced several notable findings. Hadanny et al. (2020, published in the journal Aging) conducted a randomized controlled trial in which healthy adults over 64 received 60 HBOT sessions at 2.0 ATA. The results showed significant improvements in cerebral blood flow and measurable gains in attention, information processing speed, and executive function. Brain imaging confirmed that HBOT was associated with increased blood flow to brain regions commonly affected by age-related decline.
In a related study from the same research group, Hachmo et al. (2020, published in the journal Aging) reported that HBOT increased telomere length by over 20% and reduced senescent cell populations by up to 37% in aging adults. Telomere shortening and the accumulation of senescent cells are widely recognized biological markers of aging that have been linked to cognitive decline and neurodegenerative processes. These findings suggest that HBOT may influence fundamental biological pathways associated with brain aging, though more research is needed to fully understand the long-term implications.
While these findings are encouraging, it is important to recognize that research into HBOT for age-related cognitive decline is still evolving. HBOT is not FDA-cleared for the prevention or treatment of cognitive decline or dementia. Individuals interested in exploring HBOT for cognitive support should consult with a healthcare provider to discuss the current evidence and determine whether HBOT may be appropriate for their situation.
Published Research
Research Highlights
Cognitive Function in Aging
Aging (2020) - Hadanny et al.
A randomized controlled trial found that 60 HBOT sessions at 2.0 ATA produced significant improvements in attention, information processing speed, and executive function in healthy adults over 64 years of age, with brain imaging confirming increased cerebral blood flow.
Telomere Length and Senescent Cells
Aging (2020) - Hachmo et al.
Researchers found that HBOT increased telomere length by over 20% and reduced senescent cell populations by up to 37% in aging adults, suggesting potential effects on biological markers associated with cellular aging.
Mild TBI Cognitive Recovery
PLOS ONE (2013) - Boussi-Gross et al.
Patients with mild TBI (1 to 5 years post-injury) who underwent 40 HBOT sessions at 1.5 ATA showed significant improvements in cognitive function, including memory and attention, with SPECT imaging showing corresponding improvements in brain activity.
Post-Concussion Neuroinflammation
Frontiers in Human Neuroscience - Multiple research groups
Studies have investigated HBOT for post-concussion syndrome, reporting that elevated oxygen levels under pressure may help reduce neuroinflammation and support recovery of cognitive symptoms such as brain fog and concentration difficulties.
Neuroplasticity and Brain Repair
Various Neuroscience Journals - Multiple research groups
Research suggests that HBOT may stimulate neuroplasticity by promoting the formation of new neural connections and supporting the repair of damaged white matter tracts. Increased oxygen delivery may enhance the brain's natural capacity for structural and functional reorganization.
DOD-Funded TBI Research
Department of Defense Studies - Multiple investigators
The U.S. Department of Defense has funded multiple research initiatives examining HBOT for military personnel with blast-related TBI, reflecting institutional interest in HBOT as a potential supportive therapy for brain injury recovery.
Safety and Quality
OxyHealth: The Safest Chambers Available
OxyHealth is the global leader in hyperbaric chamber manufacturing, with over 19,000 chambers delivered worldwide and more than 3,000 physicians trusting OxyHealth technology. Every chamber is built to the highest safety and quality standards in the industry. For individuals exploring HBOT for brain health concerns, the safety and reliability of the chamber is paramount.
FDA 510(k)-Cleared
All OxyHealth chambers are cleared by the U.S. Food and Drug Administration as Class II medical devices.
ASME PVHO-1
Built to the American Society of Mechanical Engineers pressure vessel standard for human occupancy.
ISO 13485 Certified
Manufactured under the international quality management standard for medical devices.
UL Listed
Electrical components are tested and certified by Underwriters Laboratories for safety compliance.
Frequently Asked Questions
HBOT and Brain Health FAQ
Hyperbaric oxygen therapy (HBOT) works by increasing atmospheric pressure around the body, which causes significantly more oxygen to dissolve into blood plasma. This oxygen-rich plasma can reach brain tissue more effectively than red blood cells alone, including areas where blood flow may be compromised. Research from Tel Aviv University (Hadanny et al., 2020, published in the journal Aging) suggests that repeated HBOT sessions may support neuroplasticity, improve cerebral blood flow, and enhance cognitive function in aging adults. Always consult a physician before starting any HBOT protocol for neurological concerns.
Research into HBOT for traumatic brain injury is an active area of investigation. Studies published in PLOS ONE (Boussi-Gross et al., 2013) have reported improvements in cognitive function and quality of life in patients with mild TBI who underwent a course of hyperbaric oxygen therapy. Department of Defense-funded research has also explored HBOT as a potential supportive therapy for military personnel with blast-related TBI. While these findings are promising, HBOT is not FDA-cleared specifically for TBI, and individuals should consult a neurologist or qualified physician to determine whether HBOT may be appropriate for their specific situation.
Studies published in Frontiers in Human Neuroscience have explored the potential of HBOT to support recovery from post-concussion syndrome. Research suggests that increased oxygen delivery under pressure may help reduce neuroinflammation, support neural tissue repair, and improve cognitive symptoms such as brain fog and difficulty concentrating. While HBOT is not FDA-cleared as a standalone concussion treatment, many sports medicine practitioners and neurologists are exploring it as a complementary therapy alongside standard concussion management protocols. A qualified healthcare provider should evaluate whether HBOT may be suitable for any individual recovering from a concussion.
The number of HBOT sessions varies depending on the individual and the specific neurological concern. Many research protocols for brain health and cognitive support involve 40 to 60 sessions over a period of several weeks. The Tel Aviv University studies on cognitive function in aging adults used protocols of 60 sessions at 2.0 ATA. For mild TBI and post-concussion support, some protocols in published literature have used 40 sessions. Consistency is important, as the benefits of HBOT appear to build with repeated treatments. A healthcare provider experienced with HBOT can recommend the right protocol based on your specific needs.
A landmark study from Tel Aviv University (Hachmo et al., 2020, published in the journal Aging) found that a protocol of 60 HBOT sessions increased telomere length by over 20% and reduced senescent cell populations by up to 37% in aging adults. Additional research from the same group (Hadanny et al., 2020) demonstrated significant improvements in attention, information processing speed, and executive function in healthy adults over 64 years of age following HBOT. These findings suggest that HBOT may help address some biological mechanisms associated with cognitive aging, though more research is ongoing in this field.
HBOT is considered safe when administered in FDA-cleared chambers following proper protocols. OxyHealth chambers are manufactured under ISO 13485 quality management standards and built to ASME PVHO-1 pressure vessel safety standards. However, individuals with certain neurological conditions should consult their neurologist before starting HBOT, as some conditions may require specific protocols or precautions. People with untreated seizure disorders, for example, should discuss risks and benefits with their physician. OxyHealth has delivered over 19,000 chambers worldwide with an exceptional safety record.
Mild hyperbaric therapy typically operates at 1.3 ATA in portable chambers suitable for home use. Clinical HBOT can reach pressures of 2.0 to 3.0 ATA in rigid chambers at medical facilities. Many of the published brain health studies, including the Tel Aviv University research, used clinical pressures of 2.0 ATA. The appropriate pressure level depends on the specific neurological concern and should be determined by a healthcare provider. OxyHealth offers both portable chambers for home use and clinical chambers for medical facilities, ensuring access to the right technology for different applications.
HBOT is often explored as a complementary therapy alongside other brain health approaches. Physicians may recommend combining HBOT with cognitive rehabilitation, physical therapy, nutritional support, and other evidence-based interventions. For individuals with TBI or post-concussion syndrome, HBOT is sometimes incorporated into a comprehensive recovery plan that includes rest, gradual return to activity, and neuropsychological support. Always work with a qualified healthcare team to determine the most appropriate combination of therapies for your specific situation.
Learn More